KITE

3 Stocks to Watch Tuesday: Kite Pharma Inc (KITE), Array Biopharma Inc (ARRY) and Mylan NV (MYL)

Kite Pharma (KITE) has promising results from its cancer drug's trial, Array Biopharma (ARRY) still is cruising on Monday's news and Mylan (MYL) won't let its scandal die.

23 Biotechnology Stocks to Sell Now

This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

13 Biotechnology Stocks to Sell Now

The ratings of 13 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biggest Movers in Manufacturing Stocks Now – JUNO KURA LOXO CXDC

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – EBIO ISNS SODA TASR

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

10 Biotech Stocks With Big Catalysts Coming This Quarter

Fans of binary trading events should find that these biotech stocks are well poised for big-time volatility over the course of the next several weeks.

Why Sprint Corp (S), Zulily Inc (ZU) and Kite Pharma Inc (KITE) Are 3 of Today’s Best Stocks

Growing confidence among homebuilders overcame a weak manufacturing report today, while Sprint, Zulily and Kite Pharma sprinted out to a big day.

8 Biotechnology Stocks to Buy Now

This week, eight biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

Why Wynn Resorts, SAP and Kite Pharma Are 3 of Today’s Worst Stocks

Wynn Resorts, Limited, SAP SE and Juno Therapeutics Inc. led the bearish charge today. Here's what investors will want to know.